Therapy of follicular lymphoma (Q79745524)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287964%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

review article

1 reference

title

[Therapy of follicular lymphoma] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287964%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

C Buske

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287964%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

M Unterhalt

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287964%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

W Hiddeman

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287964%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

publication date

1 April 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287964%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287964%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287964%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287964%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

372-381

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287964%20AND%20SRC:MED&resulttype=core&format=json

CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma

25 December 2019

cites work

1 reference

12 December 2020

High-dose therapy followed by autologous purged stem-cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by GOELAMS.

1 reference

12 December 2020

Prolonged treatment with rituximab in patients with follicular lymphoma significantly increases event-free survival and response duration compared with the standard weekly x 4 schedule

1 reference

12 December 2020

No clinical evidence for CD4+ cell depletion caused by rituximab

1 reference

12 December 2020

The Follicular Lymphoma International Prognostic Index (FLIPI) separates high-risk from intermediate- or low-risk patients with advanced-stage follicular lymphoma treated front-line with rituximab and the combination of cyclophosphamide, doxorubicin

1 reference

12 December 2020

Results of a national consensus workshop: therapeutic algorithm in patients with follicular lymphoma--role of radioimmunotherapy

1 reference

12 December 2020

Maintenance therapy with rituximab leads to a significant prolongation of response duration after salvage therapy with a combination of rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) in patients with recurring and refractory foll

1 reference

12 December 2020

Rituximab maintenance therapy in indolent NHL: a clinical review

1 reference

12 December 2020

Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP al

1 reference

12 December 2020

Clinical stage 1 non-Hodgkin's lymphoma: long-term follow-up of patients treated by the British National Lymphoma Investigation with radiotherapy alone as initial therapy

1 reference

12 December 2020

Myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission prolongs progression-free survival in follicular lymphoma: results of a prospective, randomized trial of the German Low-Grade Lymphoma Study Group

1 reference

12 December 2020

Rituximab maintenance improves clinical outcome of relapsed/resistant follicular non-Hodgkin lymphoma in patients both with and without rituximab during induction: results of a prospective randomized phase 3 intergroup trial

1 reference

12 December 2020

Standard chemotherapy with interferon compared with CHOP followed by high-dose therapy with autologous stem cell transplantation in untreated patients with advanced follicular lymphoma: the GELF-94 randomized study from the Groupe d'Etude des Lympho

1 reference

12 December 2020

10.1007/S00108-007-1804-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287964%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference